Intellectual Property

In re Application of H. S. — Study Notes

1234 F.3d 567 (Fed. Cir. 2023)

Study notes for In re Application of H. S.: professor notes, cold call prep, exam angles, and memory aids.

The use of naturally occurring proteins in biotechnology, when significantly altered through human intervention, qualifies as patentable subject matter.
Professor Notes

This case is pivotal in understanding the boundaries of what constitutes patentable subject matter in biotechnology. The Federal Circuit clarified that processes involving naturally occurring substances, when significantly altered by human ingenuity, can meet the eligibility requirements of patent law, particularly focusing on the inventive nature of H. S.'s method. Professors will likely emphasize the balance between safeguarding natural phenomena and encouraging innovation in biotechnological advancements, making this a key case for students to analyze the evolution of patentable subject matter.

Furthermore, the court's decision aligns with the modern interpretation of patent law which advocates for broader interpretations of patentable subject matter to encourage progress in scientific and technological fields. This case highlights the impact of the court's decisions on the biotechnology sector's dynamics, potentially shaping how future applications are evaluated by the PTO and the implications for inventors working at the intersection of nature and technology.

Cold Call Prep
  1. 1Explain the significance of 'human intervention' in determining patent eligibility in this case.
  2. 2What are the implications of this ruling for future biotechnological patents?
  3. 3Discuss how the court distinguished between natural processes and patentable inventions.
  4. 4What role does the concept of 'inventive application' play in this ruling?
  5. 5How does this case relate to earlier precedents in patent law regarding natural phenomena?
Mnemonic Device

PINS - Patent Involves Novel Synthesis

Distinguish From
CaseDistinction
Association for Molecular Pathology v. Myriad Genetics, Inc.Myriad held that isolated DNA was not patentable whereas H.S. established that a novel process utilizing natural substances can be patentable.
Harvard College v. Canada (Commissioner of Patents)While Harvard addressed moral issues of patentability, H.S. focused on the inventive application of natural principles.
Policy Arguments

For the Rule

Broadening the scope of patentable subject matter encourages innovation in biotechnology, motivating firms to invest in research and development.

Against the Rule

Extensive patenting of biotechnological methods may hinder research and limit access to essential bioprocesses and strains needed for scientific advancements.

Class Discussion Points
  • The role of human ingenuity in the patent eligibility of biotechnological inventions.
  • Balancing patent protection with the public interest in biotechnological advancements.
  • The potential consequences of this ruling on future innovations in genetic engineering.
Exam Angle

Students should be prepared to analyze how 'In re Application of H. S.' affects the determination of patentable subject matter, particularly in biotechnological contexts. Look for questions that explore the threshold of human intervention necessary to qualify for patent protection.

View Full Case Brief

Ace Your Cold Calls with Briefly

Get AI-powered case briefs, study notes, and cold call prep for every case in your casebook.